Functional screening assay

Details for Australian Patent Application No. 2005259235 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Buist, Arjan

Agent Shelston IP

Pub. Number AU-A-2005259235

PCT Pub. Number WO2006/003100

Priority 04076851.7 25.06.04 EP

Filing date 22 June 2005

Wipo publication date 12 January 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003100 Priority application(s): WO2006/003100

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259240-Method for transmitting packets in a transmission system

2005259231-Arylalkylamine vanadium (V) salts for the treatment and/or prevention of diabetes mellitus